Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the Cantor Virtual Global Healthcare Conference. Details are as follows:
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of S. Gail Eckhardt, M.D., to the Company’s Board of Directors. Dr. Eckhardt is a highly respected oncologist and a leader in targeted oncology drug development. “Gail brings tremendous vision and experience in translational and clinical research, with a focus on combining molecularly targeted agents to the underl
Syros Pharmaceuticals, Inc. (SYRS) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Naomi Aoki - IR Nancy Simonian - CEO Joe Ferra - CFO David Roth - CMO Conference Call Participants Phil Nadeau - Cowen and Company Ted Tenthoff - Piper Sandler Jason Butler -...